Image
|
Figure Caption
Fig. 7 Schematic presentation of the neural structures of cdx1a/4 morphant, and Fgf and/or RA signal-defected cdx1a/4 morphant embryos. (A) Wild type (wt). (B) cdx1a/4 morphants. (C) cdx1a/4 morphants that received co-injected fgf3/8MOs. (D) cdx1a/4 morphants treated with 300 μmol/l SU5402. (E) cdx1a/4 morphant embryos expressing the raldh2MO (see Fig. S4 in the supplementary material). (F) cdx1a/4 morphant embryos treated with 50 µmol/l DEAB. (G) cdx1a/4 morphant embryos treated with SU5402 and DEAB.
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Development